Question 1

What are the potential benefits of participating in this trial compared to standard treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) clinical trial (NCT01583218). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the possible side effects of betrixaban?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) clinical trial (NCT01583218). Contact the study team or your healthcare provider for specific answers.

Question 3

How long will I need to participate in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) clinical trial (NCT01583218). Contact the study team or your healthcare provider for specific answers.

Question 4

Will I need to stay in the hospital for the duration of the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) clinical trial (NCT01583218). Contact the study team or your healthcare provider for specific answers.

Question 5

What type of monitoring will be done during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) clinical trial (NCT01583218). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks I should be aware of before joining this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) clinical trial (NCT01583218). Contact the study team or your healthcare provider for specific answers.

What this study is about